US Patent Issued to The Broad Institute, Massachusetts Institute of Technology, The General Hospital on March 31 for "Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response" (Massachusetts Inventors)

ALEXANDRIA, Va., March 31 -- United States Patent no. 12,590,288, issued on March 31, was assigned to The Broad Institute Inc. (Cambridge, Mass.), Massachusetts Institute of Technology (Cambridge, Mass.) and The General Hospital Corp. (Boston).

"Method of treating an inflammatory disease by administering an agent which binds a surface receptor on a tuft cell that induces an ILC class 2 inflammatory response" was invented by Jayaraj Rajagopal (Boston), Aviv Regev (Cambridge, Mass.), Moshe Biton (Cambridge, Mass.), Adam Haber (Cambridge, Mass.), Daniel Montoro (Boston) and Ramnik Xavier (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "An atlas of intestinal epithelial cells, intestinal epithelial stem ce...